1364269-06-6

1364269-06-6 structure

Name: rac-CCT 250863
Chemical Name: 4-(2-Amino-5-{4-[(dimethylamino)methyl]-2-thienyl}-3-pyridinyl)-2-{[(3Z)-5,5,5-trifluoro-3-penten-2-yl]oxy}benzamide
CAS Number: 1364269-06-6
Molecular Formula: C₂₄H₂₅F₃N₄O₂S
Molecular Weight: 490.541
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2021-01-16 10:28:47
Modify Date: 2025-08-20 05:59:09
(Rac)-CCT 250863 (compound rac-21) is a selective and reversible NEK 2 inhibitor with an IC50 of 0.073 µM. (Rac)-CCT 250863 shows good effects of inducing cell cycle arrest and also can antiproliferative in cells (Pomalidomide sensitive/resistant). (Rac)-CCT 250863 induces apoptosis when combines with Pomalidomide[1][2].

Name	4-(2-Amino-5-{4-[(dimethylamino)methyl]-2-thienyl}-3-pyridinyl)-2-{[(3Z)-5,5,5-trifluoro-3-penten-2-yl]oxy}benzamide
Synonyms	MFCD30474714 4-(2-Amino-5-{4-[(dimethylamino)methyl]-2-thienyl}-3-pyridinyl)-2-{[(3Z)-5,5,5-trifluoro-3-penten-2-yl]oxy}benzamide Benzamide, 4-[2-amino-5-[4-[(dimethylamino)methyl]-2-thienyl]-3-pyridinyl]-2-[[(2Z)-4,4,4-trifluoro-1-methyl-2-buten-1-yl]oxy]-

Description	(Rac)-CCT 250863 (compound rac-21) is a selective and reversible NEK 2 inhibitor with an IC50 of 0.073 µM. (Rac)-CCT 250863 shows good effects of inducing cell cycle arrest and also can antiproliferative in cells (Pomalidomide sensitive/resistant). (Rac)-CCT 250863 induces apoptosis when combines with Pomalidomide[1][2].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer
Target	IC50: 0.073 µM (NEK 2), 8.0 μΜ (H929), 7.1 μΜ (AMOl), 8.7 μΜ (K12PE)[1][2].
References	[1]. Innocenti P, et al. Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: structure-activity relationship, structural biology, and cellular activity. J Med Chem. 2012 Apr 12;55(7):3228-41. [2]. Ahsan A, et al. Methods for treating cancer with combination therapies. WO2021262962A1.